Key facts
- This page summarizes Yair Nechmad's Form 3 filing for Nayax Ltd. (NYAX).
- 0 reported transactions and 5 derivative rows are listed below.
- Accepted by SEC: 16 Mar 2026, 11:54.
Key filing fact
Ownership activity is grounded in SEC Form 3 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
No transaction description listed
No transaction description listed
No transaction description listed
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
Additional SEC filing notes
Footnote F1
The shares were originally acquired as Founder Shares
Footnote F2
The shares were originally acquired as Founder Shares
Footnote F3
The Shares reported herein were purchased in the open market
Footnote F4
The reported securities represent Series 1 Warrants issued by the Company in connection with its 2025 offering of Series A Notes and Warrants. The Warrants are listed for trading on the Tel Aviv Stock Exchange
Footnote F5
Each Warrant is exercisable for one Ordinary Share at an exercise price of NIS 177.80, subject to adjustments based on changes in the NIS-to-USD exchange rate.
Footnote F6
The Stock Options are Fully vested and immediately exercisable
Footnote F7
The exercise price is denominated in New Israeli Shekels. The U.S. dollar amount reported reflects the exchange rate on the grant date.
Footnote F8
The Stock Options are Fully vested and immediately exercisable
Footnote F9
The exercise price is denominated in New Israeli Shekels. The U.S. dollar amount reported reflects the exchange rate on the grant date.
Footnote F10
The Stock Options are Fully vested and immediately exercisable
Footnote F11
The exercise price is denominated in New Israeli Shekels. The U.S. dollar amount reported reflects the exchange rate on the grant date.
Footnote F12
The Stock Options are Fully vested and immediately exercisable
Footnote F13
The exercise price is denominated in New Israeli Shekels. The U.S. dollar amount reported reflects the exchange rate on the grant date.
SEC remarks
This Form 3 is being filed to report the Reporting Persons beneficial ownership of securities of the Issuer as of the date the Reporting Person became subject to the reporting requirements of Section 16 of the Securities Exchange Act of 1934.